LAUSR

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer

Sign Up to like & get
recommendations!
0 Published in 2019 at "Case Reports in Endocrinology"

DOI: 10.1155/2019/6831237

Abstract: Background The tyrosine kinase inhibitors (TKIs) are indicated for the treatment of locally advanced or metastatic progressive thyroid carcinoma (CDT), refractory to radioactive iodine. The following report describes the efficacy of lenvatinib administered through a… read more here.

Keywords: lenvatinib; poorly differentiated; administered via; differentiated thyroid ... See more keywords